Executive Summary The Tardive Dyskinesia Treatment Market continues to evolve as a critical segment within the neurological disorders therapeutic landscape. This involuntary movement disorder, predominantly affecting patients receiving long-term antipsychotic therapy, has garnered significant attention from healthcare providers, pharmaceutical companies, and regulatory authorities worldwide. Market intelligence suggests that the treatment paradigm for tardive dyskinesia is… Read.